Charles River Newsroom

Mizuho Securities Maintains Charles River(CRL.US) With Hold Rating

Moomoo NewsAug 13 13:31 ET

Hold Rating on Charles River Labs Amidst Pharma Restructuring and Uncertain Near-Term Earnings

TipRanksAug 13 13:01 ET

Mizuho Adjusts Price Target on Charles River Laboratories International to $210 From $235, Maintains Neutral Rating

MT NewswiresAug 13 05:54 ET

Charles River Analyst Ratings

BenzingaAug 12 11:02 ET

Analysts Offer Insights on Healthcare Companies: AnaptysBio (ANAB), Charles River Labs (CRL) and Akero Therapeutics (AKRO)

TipRanksAug 12 06:37 ET

Charles River Analyst Ratings

BenzingaAug 8 15:18 ET

Baird Cuts Charles River Labs to Neutral, Cites Lagging Recovery

Seeking AlphaAug 8 15:05 ET

Morgan Stanley Cuts Price Target on Charles River Laboratories International to $215 From $235

MT NewswiresAug 8 14:35 ET

Analysts Offer Insights on Healthcare Companies: Outset Medical (OM), Rani Therapeutics Holdings (RANI) and Charles River Labs (CRL)

TipRanksAug 8 09:45 ET

Barclays Keeps Their Hold Rating on Charles River Labs (CRL)

TipRanksAug 8 08:31 ET

Charles River Labs Price Target Cut to $191.00/Share From $239.00 by Baird

Dow JonesAug 8 05:34 ET

Charles River Analyst Ratings

BenzingaAug 8 05:27 ET

Deutsche Bank Adjusts Price Target on Charles River Laboratories International to $240 From $300

MT NewswiresAug 7 11:55 ET

Stephens Adjusts Price Target on Charles River Laboratories International to $250 From $280

MT NewswiresJul 16 09:10 ET

Charles River Analyst Ratings

BenzingaJul 10 08:15 ET

Charles River Analyst Ratings

BenzingaJun 28 08:22 ET

Charles River Analyst Ratings

BenzingaJun 7 06:42 ET

Charles River Analyst Ratings

BenzingaJun 6 08:58 ET

Charles River Analyst Ratings

BenzingaMay 13 12:20 ET

Charles Rhyee Maintains Hold on Charles River Labs Amidst Revenue and Market Uncertainties

TipRanksMay 12 21:00 ET